Merck KGaA (MKKGY)
30.99
-0.07
(-0.23%)
USD |
OTCM |
Oct 12, 16:00
Merck Cash from Investing (Quarterly) : -710.40M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -710.40M |
| March 31, 2026 | -883.30M |
| December 31, 2025 | -682.85M |
| September 30, 2025 | -3.534B |
| June 30, 2025 | -169.57M |
| March 31, 2025 | -440.98M |
| December 31, 2024 | -697.87M |
| September 30, 2024 | -1.842B |
| June 30, 2024 | -28.84M |
| March 31, 2024 | -747.81M |
| December 31, 2023 | -464.25M |
| September 30, 2023 | -385.44M |
| June 30, 2023 | 138.52M |
| March 31, 2023 | -1.321B |
| December 31, 2022 | -199.20M |
| September 30, 2022 | -604.72M |
| June 30, 2022 | -832.05M |
| March 31, 2022 | -1.222B |
| December 31, 2021 | -399.34M |
| September 30, 2021 | -760.91M |
| June 30, 2021 | -290.13M |
| March 31, 2021 | -416.75M |
| December 31, 2020 | -146.29M |
| September 30, 2020 | -836.25M |
| June 30, 2020 | -234.42M |
| Date | Value |
|---|---|
| March 31, 2020 | -317.28M |
| December 31, 2019 | -5.252B |
| September 30, 2019 | -238.53M |
| June 30, 2019 | -980.71M |
| March 31, 2019 | -373.57M |
| December 31, 2018 | 3.346B |
| September 30, 2018 | -251.32M |
| June 30, 2018 | -239.40M |
| March 31, 2018 | -261.78M |
| December 31, 2017 | -412.38M |
| September 30, 2017 | -126.81M |
| June 30, 2017 | -327.90M |
| March 31, 2017 | -430.52M |
| December 31, 2016 | -499.77M |
| September 30, 2016 | -248.29M |
| June 30, 2016 | -123.97M |
| March 31, 2016 | 313.17M |
| December 31, 2015 | -16.28B |
| September 30, 2015 | 461.18M |
| June 30, 2015 | 2.063B |
| March 31, 2015 | 434.90M |
| December 31, 2014 | -1.978B |
| September 30, 2014 | -20.52M |
| June 30, 2014 | -2.167B |
| March 31, 2014 | 1.506B |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| STRATEC SE | -3.83M |
| Sartorius AG | -175.22M |
| Petros Pharmaceuticals, Inc. | 0.00 |
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 706.85M |
| Cash from Financing (Quarterly) | -920.17M |
| Free Cash Flow | 38.93M |
| Free Cash Flow Per Share (Quarterly) | -0.2575 |
| Free Cash Flow to Equity (Quarterly) | -754.56M |
| Free Cash Flow to Firm (Quarterly) | -436.92M |
| Free Cash Flow Yield | 0.06% |